[1] |
Bertani L, Rossari F, Barberio B, et al. Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio[J]. Inflamm Bowel Dis, 2020, 26(10): 1579-1587.
|
[2] |
Zilbauer M, Heuschkel R. Disease Prognostic Biomarkers in Inflammatory Bowel Diseases-A Reality Check[J]. J Crohns Colitis, 2022, 16(1): 162-165.
|
[3] |
Yerushalmy-Feler A, Singer D, Berkovitch G, et al. Predictors for poor outcome of hospitalized children with inflammatory bowel disease[J]. Eur J Pediatr, 2020, 179(1): 157-164.
|
[4] |
Hyams JS, Davis Thomas S, Gotman N, et al. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study[J]. Lancet, 2019, 393(10182): 1708-1720.
|
[5] |
Ueno N, Sugiyama Y, Kobayashi Y, et al. Fecal calprotectin is a useful biomarker for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis in ulcerative colitis patients: a prospective observation study[J]. BMC Gastroenterol, 2021, 21(1): 316.
|
[6] |
Singh S, Ananthakrishnan AN, Nguyen NH, et al. AGA Clinical Guidelines Committee. Electronic address: clinicalpractice@gastro. org. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis[J]. Gastroenterology, 2023, 164(3): 344-372.
|
[7] |
de Carvalho LGF, Lima WG, Coelho LGV, et al. Circulating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis[J]. Inflamm Bowel Dis, 2021, 27(2): 169-181.
|
[8] |
Liu Z, Tang H, Liang H, et al. Dyslipidaemia Is Associated with Severe Disease Activity and Poor Prognosis in Ulcerative Colitis: A Retrospective Cohort Study in China[J]. Nutrients, 2022, 14(15): 3040.
|
[9] |
Amiot A, Bouguen G, Bonnaud G, et al. French National Consensus Clinical guidelines for the management of IBD study group. Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus[J]. Dig Liver Dis, 2021, 53(1): 35-43.
|
[10] |
Barreiro-de Acosta M, Armuzzi A. Outcome predictors in acute severe ulcerative colitis[J]. Dig Liver Dis, 2023, 55(9): 1167-1168.
|
[11] |
中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中华炎性肠病杂志, 2018, 2(3): 173-190.
|
[12] |
Yamamoto-Furusho JK, Mendieta-Escalante EA. Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis[J]. PLoS One, 2020, 15(4): e0231988.
|
[13] |
Nguyen NH, Picetti D, Dulai PS, et al. Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic Review[J]. J Crohns Colitis, 2022, 16(3): 398-413.
|
[14] |
Feng W, Liu Y, Zhu L, et al. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential markers for ulcerative colitis: a retrospective study[J]. BMC Gastroenterol, 2022, 22(1): 485.
|
[15] |
Sakurai T, Saruta M. Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease[J]. Digestion, 2023, 104(1): 30-41.
|
[16] |
Ishida N, Higuchi T, Miyazu T, et al. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis[J]. Sci Rep, 2021, 11(1): 12431.
|
[17] |
Huang J, Lu J, Jiang F, et al. Platelet/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing endoscopic inflammatory bowel disease severity[J]. BMC Gastroenterol, 2023, 23(1): 393.
|
[18] |
Yoon H, Jangi S, Dulai PS, et al. Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis[J]. Gastroenterology, 2020, 159(4): 1262-1275.
|
[19] |
Furukawa S, Yagi S, Shiraishi K, et al. Effect of disease duration on the association between C-reactive protein-albumin ratio and endoscopic activity in ulcerative colitis[J]. BMC Gastroenterol, 2022, 22(1): 39.
|
[20] |
Abd El Hafez A, Mohamed AS, Shehta A, et al. Neutrophil extracellular traps-associated protein peptidyl arginine deaminase 4 immunohistochemical expression in ulcerative colitis and its association with the prognostic predictors[J]. Pathol Res Pract, 2020, 216(10): 153102.
|
[21] |
Geng B, Ding X, Li X, et al. Peripheral blood T-lymphocyte subsets are potential biomarkers of disease severity and clinical outcomes in patients with ulcerative colitis: a retrospective study[J]. BMC Gastroenterol, 2023, 23(1): 136.
|
[22] |
Huang X, Liu Y, Zhou Z, et al. Clinical significance of the C-reactive protein-to-bilirubin ratio in patients with ulcerative colitis[J]. Front Med(Lausanne), 2023, 10(1): 1227998.
|
[23] |
Chen XF, Zhao Y, Guo Y, et al. Predictive value of fibrinogen in identifying inflammatory bowel disease in active stage.[J]. BMC Gastroenterol, 2021, 21(1): 472.
|
[24] |
Zhang C, Chen H, He Q, et al. Fibrinogen/AKT/Microfilament Axis Promotes Colitis by Enhancing Vascular Permeability[J]. Cell Mol Gastroenterol Hepatol, 2021, 11(3): 683-696.
|
[25] |
屈霄, 王靓, 陆萍, 等. 外周血炎症因子及肠道菌群特征与活动性溃疡性结肠炎患者病情的相关性分析[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(6): 466-470.
|
[26] |
Liu A, Lv H, Tan B, et al. Accuracy of the highly sensitive C-reactive protein/albumin ratio to determine disease activity in inflammatory bowel disease[J]. Medicine(Baltimore), 2021, 100(14): e25200.
|
[27] |
Rivière P, Le Chevillier A, Rullier A, et al. Deep ulcers are associated with increased C-reactive protein in active ulcerative colitis.[J]. Dig Liver Dis, 2023, 55(9): 1194-1200.
|
[28] |
Croft A, Lord A, Radford-Smith G. Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?[J]. J Crohns Colitis, 2022, 16(7): 1089-1096.
|
[29] |
Con D, Andrew B, Nicolaides S, et al. Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein(CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy[J]. Intest Res, 2022, 20(1): 101-113.
|
[30] |
叶熳丽, 王玲莉, 黄象维, 等. 纤维蛋白原与清蛋白比值在溃疡性结肠炎诊断及病情评估中的应用研究[J]. 中国卫生检验杂志, 2022, 32(003): 315-318.
|
[31] |
邓蓓莹, 田山, 胡嘉铭, 等. 中性粒细胞与白蛋白比值在溃疡性结肠炎活动判断中的临床价值[J]. 临床内科杂志, 2023, 40(3): 185-187.
|
[32] |
Pan J, Li J, Gao Y. The value of 7 peripheral blood serum ratios in diagnosis and prediction of disease activity of patients within inflammatory bowel disease individuals[J]. Front Med(Lausanne), 2023, 10(1): 1122005.
|